X4 Pharmaceuticals to Engage with Investors at Upcoming Conference
X4 Pharmaceuticals to Engage with Investors at Upcoming Conference
X4 Pharmaceuticals (Nasdaq: XFOR), a leader in developing therapies for rare immune diseases, is set to participate in the Stifel 2024 Healthcare Conference. This prestigious conference will take place in New York City on the 18th and 19th of November. It's an essential platform for the company to connect with investors and share their progress towards advancing patient care.
Conference Details
At the conference, X4 Pharmaceuticals will participate in a fireside chat scheduled for 4:10 PM ET on the first day. This format allows for an engaging discussion where key company representatives will showcase their latest developments and answer critical questions from the audience.
The conference presents an invaluable opportunity for X4 Pharmaceuticals to discuss their innovative therapies that aim to meet the significant unmet needs in the patient community. After the event, a live webcast replay will be available for those who wish to revisit the discussions and insights shared.
About X4 Pharmaceuticals
X4 Pharmaceuticals is deeply committed to improving the lives of patients with rare diseases affecting the immune system. They leverage their expertise in CXCR4 biology to develop mavorixafor, a medication Sapproved by the U.S. FDA as XOLREMDI, designed to treat specific conditions associated with this pathway.
The company continues to explore additional indications for mavorixafor, underscoring their dedication to research and development in addressing diverse medical needs. X4's headquarters are situated in Boston, Massachusetts, with a dedicated research center located in Vienna, Austria, emphasizing their global reach in scientific innovation.
Innovative Therapies for Rare Diseases
X4 Pharmaceuticals aims to drive significant advancements in therapeutic offerings for patients with rare immune diseases. With an unwavering focus on patient care, the company is at the forefront of developing advanced therapies that not only treat symptoms but aim for better health outcomes.
Connecting with Investors
During the Stifel conference, X4 Pharmaceuticals will also facilitate one-on-one meetings with interested investors. This approach enhances engagement and allows for deeper dialogues regarding the company's strategies, potential investments, and future projects.
Investors and stakeholders are encouraged to connect with their Stifel representatives to schedule these individualized discussions, ensuring a comprehensive understanding of X4's mission and vision.
Company Contacts for Further Information
For more information about X4 Pharmaceuticals, please reach out to:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com
Daniel Ferry
Managing Director, LifeSci Advisors
Contact: (617) 430-7576
daniel@lifesciadvisors.com
Frequently Asked Questions
What is the purpose of the Stifel 2024 Healthcare Conference?
The conference is designed for biotech companies like X4 Pharmaceuticals to showcase their developments in therapies and connect with investors.
What date will X4 Pharmaceuticals participate in the conference?
X4 Pharmaceuticals will participate in the Stifel 2024 Healthcare Conference on November 18, 2024.
What is mavorixafor and its significance?
Mavorixafor is X4's innovative therapy approved by the U.S. FDA for treating rare diseases related to immune system deficiencies.
Where is X4 Pharmaceuticals headquartered?
X4 Pharmaceuticals is headquartered in Boston, Massachusetts, with a research center in Vienna, Austria.
How can investors learn more about X4 Pharmaceuticals?
Interested investors can contact the company directly via the provided emails or visit their official website for more information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.